Your browser doesn't support javascript.
loading
Diagnosis and Treatment of Chronic Lymphocytic Leukemia: Recommendations of the French CLL Study Group (FILO).
Quinquenel, Anne; Aurran-Schleinitz, Thérèse; Clavert, Aline; Cymbalista, Florence; Dartigeas, Caroline; Davi, Frédéric; de Guibert, Sophie; Delmer, Alain; Dilhuydy, Marie-Sarah; Feugier, Pierre; Fornecker, Luc-Matthieu; Ghez, David; Guieze, Romain; Laribi, Kamel; Leblond, Véronique; Leprêtre, Stéphane; Letestu, Rémi; Lévy, Vincent; Nguyen-Khac, Florence; Michallet, Anne-Sophie; Tomowiak, Cécile; Tournilhac, Olivier; Ysebaert, Loïc; Troussard, Xavier.
Afiliação
  • Quinquenel A; Centre Hospitalier Universitaire (CHU) de Reims, Hôpital Robert Debré, Reims, France.
  • Aurran-Schleinitz T; Université Reims Champagne-Ardenne, unité de Formation et de recherche (UFR) Médecine, Reims, France.
  • Clavert A; Institut Paoli Calmettes, Marseille, France.
  • Cymbalista F; CHU d'Angers, Angers, France.
  • Dartigeas C; Groupe des Hôpitaux Universitaires Paris Seine Saint-Denis (GHUPSSD), Assistance Publique Hôpitaux de Paris (AP-HP), Bobigny, France.
  • Davi F; Unité Mixte de recherche (UMR) U978 INSERM, Bobigny, France.
  • de Guibert S; Université Paris 13, UFR Santé Médecine Biologie Humaine (SMBH), Bobigny, France.
  • Delmer A; CHU de Tours, Tours, France.
  • Dilhuydy MS; Sorbonne Université, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France.
  • Feugier P; CHU de Rennes, France.
  • Fornecker LM; Centre Hospitalier Universitaire (CHU) de Reims, Hôpital Robert Debré, Reims, France.
  • Ghez D; Université Reims Champagne-Ardenne, unité de Formation et de recherche (UFR) Médecine, Reims, France.
  • Guieze R; CHU de Bordeaux, Pessac, France.
  • Laribi K; CHU Nancy, Vandoeuvre les Nancy, France.
  • Leblond V; Institut de Cancerologie de Strasbourg Europe, Strasbourg, France.
  • Leprêtre S; INSERM S-113, Strasbourg, France.
  • Letestu R; Institut Gustave Roussy, Villejuif, France.
  • Lévy V; CHU de Clermont Ferrand, Clermont-Ferrand, France.
  • Nguyen-Khac F; Centre Hospitalier du Mans, Le Mans, France.
  • Michallet AS; Sorbonne Université, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France.
  • Tomowiak C; Inserm U1245 and Department of Hematology, Centre Henri Becquerel and Normandie Univ UNIROUEN, Rouen, France.
  • Tournilhac O; Groupe des Hôpitaux Universitaires Paris Seine Saint-Denis (GHUPSSD), Assistance Publique Hôpitaux de Paris (AP-HP), Bobigny, France.
  • Ysebaert L; Unité Mixte de recherche (UMR) U978 INSERM, Bobigny, France.
  • Troussard X; Université Paris 13, UFR Santé Médecine Biologie Humaine (SMBH), Bobigny, France.
Hemasphere ; 4(5): e473, 2020 Oct.
Article em En | MEDLINE | ID: mdl-33062946
As a result of significant recent developments, the management of patients with chronic lymphocytic leukemia (CLL) is changing, and new therapeutic options will continue to emerge in the near future. The recommendations of the French Innovative Leukemia Organization (FILO-CLL) group presented here are intended to provide practical recommendations for physicians taking care of CLL patients, taking into account the availability of both biological tests and therapies in daily practice in France at the time of publication. This text details the documented information and guidelines on diagnosis, indications for treatment, infectious complications and therapeutic strategies in frontline and relapsed CLL as well as in particular conditions such as autoimmune cytopenia or Richter syndrome.
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Guideline Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Guideline Idioma: En Ano de publicação: 2020 Tipo de documento: Article